Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

MicroRNA-24/MODY gene regulatory pathway mediates pancreatic β-cell dysfunction

  • Yunxia Zhu
  • , Weiyan You
  • , Hongdong Wang
  • , Yating Li
  • , Nan Qiao
  • , Yuguang Shi
  • , Chenyu Zhang
  • , David Bleich
  • , Xiao Han

Producción científica: Article › revisión exhaustiva

Resumen

Overnutrition and genetics both contribute separately to pancreatic β-cell dysfunction, but how these factors interact is unclear. This study was aimed at determining whether microRNAs (miRNAs) provide a link between these factors. In this study, miRNA-24 (miR-24) was highly expressed in pancreatic β-cells and further upregulated in islets from genetic fatty (db/db) or mice fed a high-fat diet, and islets subject to oxidative stress. Overexpression of miR-24 inhibited insulin secretion and β-cell proliferation, potentially involving 351 downregulated genes. By using bioinformatic analysis combined with luciferase-based promoter activity assays and quantitative real-time PCR assays, we identified two maturity-onset diabetes of the young (MODY) genes as direct targets of miR-24. Silencing either of these MODY genes (Hnf1a and Neurod1) mimicked the cellular phenotype caused by miR-24 overexpression, whereas restoring their expression rescued β-cell function. Our findings functionally link the miR-24/MODY gene regulatory pathway to the onset of type 2 diabetes and create a novel network between nutrient overload and genetic diabetes via miR-24.

Idioma originalEnglish (US)
Páginas (desde-hasta)3194-3206
Número de páginas13
PublicaciónDiabetes
Volumen62
N.º9
DOI
EstadoPublished - sept 2013
Publicado de forma externaSí

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Huella

Profundice en los temas de investigación de 'MicroRNA-24/MODY gene regulatory pathway mediates pancreatic β-cell dysfunction'. En conjunto forman una huella única.

Citar esto